Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Cantor Fitzgerald
Johnson and Johnson
Accenture
Covington
UBS
Harvard Business School
Baxter
US Army

Generated: November 20, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Tasisulam

« Back to Dashboard

US Patents for Tasisulam

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Tasisulam ➤ Sign Up Thiophene-amd thiazolesulfonamides as antineoplastic agents Eli Lilly and Company (Indianapolis, IN) ➤ Sign Up
Tasisulam ➤ Sign Up Thiophene-and thiazolesulfonamides as antineoplastic agents Eli Lilly and Company (Indianapolis, IN) ➤ Sign Up
Tasisulam ➤ Sign Up TGF-beta receptor inhibitors to enhance direct reprogramming The General Hospital Corporation (Boston, MA) ➤ Sign Up
Tasisulam ➤ Sign Up TGF-beta receptor inhibitors to enhance direct reprogramming The General Hospital Corporation (Boston, MA) ➤ Sign Up
Tasisulam ➤ Sign Up Generation of vascularized human heart tissue and uses thereof The General Hospital Corporation (Boston, MA) ➤ Sign Up
Tasisulam ➤ Sign Up Use of sulfonamide-including compounds in combination with angiogenesis inhibitors Eisai R&D Management Co., Ltd. (Tokyo, JP) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Tasisulam

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
Tasisulam Argentina 037248 2021-10-25 ➤ Sign Up
Tasisulam Austria 338033 2021-10-25 ➤ Sign Up
Tasisulam Australia 2002334817 2021-10-25 ➤ Sign Up
Tasisulam Brazil 0212386 2021-10-25 ➤ Sign Up
Tasisulam Canada 2463300 2021-10-25 ➤ Sign Up
Tasisulam China 1298709 2021-10-25 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Argus Health
Accenture
Cerilliant
Daiichi Sankyo
Chinese Patent Office
Johnson and Johnson
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: